SARS-CoV-2 Mpro-IN-42
SARS-CoV-2 Mpro-IN-42 (compound C5) is a potent SARS-CoV-2 Mpro inhibitor with an IC50 of 33.6 nM. SARS-CoV-2 Mpro-IN-42 can be used in the study of SARS-CoV-2[1].
Product Specifications
UNSPSC
12352005
Target
SARS-CoV
Related Pathways
Anti-infection
Applications
COVID-19-anti-virus
Field of Research
Infection
Smiles
N#CC1=NN(C2=CC=C(C(F)(F)F)C(F)=C2)C(N(CC(C3=NC=CC=C3)=O)C1=O)=O
Molecular Formula
C18H9F4N5O3
Molecular Weight
419.29
References & Citations
[1]Yang Z, et al. A deep learning model for structure-based bioactivity optimization and its application in the bioactivity optimization of a SARS-CoV-2 main protease inhibitor. Eur J Med Chem. 2025 Jul 5;291:117602.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
NBP2-33170DL594 0.1 mL
Mouse Monoclonal Cytokeratin, HMW Antibody (AE-3) [DyLight 594]
Ask
View Details 
MBS8114641-01 0.3 mg
Human Protein Kinase D2/PRKD2 Baculovirus-Insect cells Overexpression Lysate
Ask
View Details MBS8114641-02 5x 0.3 mg
Human Protein Kinase D2/PRKD2 Baculovirus-Insect cells Overexpression Lysate
Ask
View Details